Massive team effort to start The Alfred Prostate Stereotactic Ablative Body Radiotherapy (SABR) program - first public centre in Victoria to offer prostate SABR as standard of care treatment options on CT-Linac, cutting down treatment from 20 to 5 visits for prostate cancer!

Final anlyses of the Sunnybrook Health Sciences Centre GLIO study that proved tumour migration during fractionated rads for high grade glioma and now reporting prognostic relevance. Congrats to our prior fellow Dr. Wee Ong from 🇦🇺 and supervisor Dr. Myrehaug. pubmed.ncbi.nlm.nih.gov/38561051/

Good catch-up and moderating ISRSy #ISRSUSA2024 GU prostate SABR session with Rohann Correa, co-fellows Sunnybrook Health Sciences Centre Radiation Oncology Dr. Andrew Loblaw

Good to see RADICALS-HD in print. THanks to numerous colleagues and collaborators over 20 years authors.elsevier.com/sd/article/S01…

Team Aussie 🇦🇺 at #ReCOG. Definitely lots of collective work/ opportunities (eg reirradiation registry) to improve ReRT Down Under! Nick Hardcastle @RANZCRCollege

Another major milestone for The Alfred Radiation Oncology - now offering prostate SABR at our satellite site at Latrobe Regional Health LRH | Hospital, making treatment more convenient for men with prostate cancer in regional Victoria! Monash Partners Comprehensive Cancer Consortium (photo with patient consent)

Burnout & moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve learned to combat it - I hope others find it to be helpful. In Search of Joy and Meaning in Modern Medicine JCO Oncology Practice ascopubs.org/doi/pdf/10.120…

Online First: #Palliative #radiotherapy versus best supportive care in patients with painful #hepaticcancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study #radonc thelancet.com/journals/lanon…

#PACE A published in European Urology! SBRT vs Radical prostatectomy. Spread the word #SBRT should be discussed with eligible patients ⁦Dr Shaun Tolan⁩ Alison Tree 💙⁩ ⁦Clive Peedell⁩ Dr. Andrew Loblaw⁩ ⁦Prof Emma Hall⁩ Prof Joe O'Sullivan⁩ authors.elsevier.com/sd/article/S03…

Thomas Kennedy leads 10y prostate #SBRT outcomes from 3 different prospective studies now epub at #RedJ IJROBP - The Red Journal doi.org/10.1016/j.ijro… Great biochemical control to 15 years and only 1% chance of mets! Note 10% of UIR pts received ADT and none had whole pelvic RT (-> #PR24)

🙏Thanks to mentoring by Amar Kishan , stats support by Tahmineh Romero, and contributions by coauthors 🙏 Thanks to funding from RANZCR-TROG research grant RANZCR Trans Tasman Radiation Oncology Group 🙏Thanks to patients from multiple trials who contributed data for the analysis

After 4 years of the GÖTEBORG-2 trial, MRI-targeted biopsy led to less detection of clinically insignificant prostate cancer than systematic biopsy without compromising the detection of cancer that may affect survival. Read the full trial results: nej.md/4ewOjKT

In patients with muscle-invasive bladder cancer, extended lymphadenectomy did not improve disease-free or overall survival as compared with the standard procedure and was associated with higher morbidity and mortality. Full SWOG S1011 trial results: nej.md/4dBI8UN

Delighted to share the results of #PACE B trial, published in NEJM today 5 fraction SBRT is non inferior to CRT! nejm.org/media/doi/full… Alison Tree 💙 Follow us on Bluesky @ICR-CTSU Prof Emma Hall The Royal Marsden NHS Foundation Trust Dr. Andrew Loblaw Clive Peedell ST Prof Joe O'Sullivan Prof Suneil Jain

excited that we are now offering prostate SABR at Barwon Health Andrew Love Cancer Center, benefiting men with prostate cancer in western regional Victoria! Victorian Department of Health Targeting Cancer

As #RANZCR2024 comes to a close, it is my honour to be the RO convenor for #RANZCR2025, with a line-up of esteemed international speakers (more TBC). Please save the date, and see you in Melbourne 23-25 October 2025! Amar Kishan arjun sahgal Dr. Nina Niu Sanford Dr. Fabio Moraes

Wee Loon Ong leads pub in European Urology Oncology for #PATRIOT (#SBRT weekly vs every other day treatment for favourable risk #prostatecancer ) No stat diff in bioc fail (mFU of 91mo) Planning to combine with Thomas Zilli #NOVALIS study (same design) free link👉tinyurl.com/yyhd69c2

📢 STORM trial breaking results at #ESTRO25! 🧪 MDT vs ENRT+MDT for nodal oligorecurrent PCa. 🧬 ENRT+MDT: ✅ Superior bRFS (57% vs 41%, p=0.014) ✅ Superior pelvic control (lrRFS 85% vs 62%, p=0.006) ✅ Superior MFS (76% vs 63%, p=0.06) ❌ No increase in ≥G2 GU/GI toxicity

New review led by Deep Chakrabarti of The Royal Marsden NHS Foundation Trust outlines global trends and evolving diagnostics, treatment, and surveillance of #ProstateCancer. Read: acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… Chris Parker Amar Kishan Vedang Murthy Nicholas van As Alison Tree 💙 Advanced Prostate Cancer Consensus Conference The ICR

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a phase 3 thelancet.com/journals/lanon… Authors: Alison Tree 💙, Nicholas van As, & Prof Emma Hall The Royal Marsden Cancer Charity, Accuray, The ICR